ADGRG1 and leukemia: To determine whether GPR56 suppression affected the leukemia initiating capacity, a hallmark of LSCs (Lapidot et al, 1994), we transplanted patient‐derived xenograft cells in immunocompromised mice after short overnight lentiviral transduction to avoid effects of GPR56 suppression before injection.